YI
111, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CN
$3.14
+0.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.61x
- Price / sales
- 0.02x
- Price / cash flow
- -5.24x
Enterprise value
- Enterprise value
- $152.7M
- EV / sales
- 0.10x
- EV / EBITDA
- -35.32x
- EV / EBIT
- -20.36x
- Market cap
- $27.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026